Entia Biosciences Inc. announced the resignation of Carl J. Johnson from his positions as President, Chief Executive Officer and as a member of the company's Board of Directors. The company's Board of Directors has appointed Timothy A. Timmins as President and Chief Executive Officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -.--% | -.--% | -.--% |
2017 | Entia Biosciences, Inc. Announces Management Changes | CI |
2017 | Entia Biosciences, Inc Auditor Raises 'Going Concern' Doubt | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 3.41K | |
+3.13% | 42.11B | |
+48.83% | 40.08B | |
+8.49% | 40B | |
-10.82% | 26.87B | |
+8.26% | 24.58B | |
-23.69% | 18.44B | |
+1.58% | 11.94B | |
+32.83% | 11.66B | |
+6.63% | 11.01B |
- Stock Market
- Equities
- ERGO Stock
- News Entia Biosciences, Inc.
- Entia Biosciences, Inc. Announces Management Changes